Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP2 | P42575 | 1/20 | 0.40 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.40 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.40 |
| ▸ | TLR2 | O60603 | 2/20 | 0.39 |
| ▸ | CNR1 | P21554 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
| ▸ | CTSD | P07339 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 3/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.35 |
| ▸ | MMP1 | P03956 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 1/20 | 0.34 |
| ▸ | MMP3 | P08254 | 1/20 | 0.34 |
| ▸ | MMP9 | P14780 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12581765 | 0.95 | SLC6A5 (0.37) | CASP2MCL1SLC6A5TLR2CNR1 | |
| SCHEMBL24335047 | 0.89 | CASP2 (0.50) | CASP2SLC6A5TLR2CNR1TSHR | |
| SCHEMBL25835301 | 0.89 | CASP2 (0.46) | CASP2SLC6A5TLR2TSHRCTSD | |
| SCHEMBL29336777 | 0.88 | CASP2 (0.49) | CASP2SLC6A5TLR2CNR1TSHR | |
| SCHEMBL2124347 | 0.86 | CASP2 (0.44) | CASP2MCL1CNR1TSHRNAAA | |
| SCHEMBL25835672 | 0.85 | CASP2 (0.48) | CASP2SLC6A5TLR2TSHRCTSD | |
| SCHEMBL16351211 | 0.85 | TSHR (0.48) | CASP2SLC6A5TLR2TSHRNAAA | |
| SCHEMBL26033143 | 0.85 | CASP2 (0.59) | CASP2SLC6A5TLR2NAAAFAAH | |
| SCHEMBL24860088 | 0.85 | CASP2 (0.59) | CASP2SLC6A5TLR2NAAAFAAH | |
| SCHEMBL22338483 | 0.85 | FAAH (0.44) | MCL1SLC6A5TLR2TSHRFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230226193-A1 | LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS | Arrowhead Pharmaceuticals, Inc. | 2023-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230226193-A1 | LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS | CPT1B, MUSK, MYLK2 | CASP2 4430/4885MCL1 867/4885SLC6A5 4323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.